Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93010622 | 9301062 | 2 | F | 20120423 | 20160824 | 20130521 | 20160902 | EXP | US-PFIZER INC-2012185860 | PFIZER | 78.00 | YR | M | Y | 81.18000 | KG | 20160902 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93010622 | 9301062 | 1 | PS | CELECOXIB. | CELECOXIB | 1 | Oral | UNK | 20998 | CAPSULE, HARD | |||||||||
| 93010622 | 9301062 | 2 | SS | CELECOXIB. | CELECOXIB | 1 | 20998 | CAPSULE, HARD | |||||||||||
| 93010622 | 9301062 | 3 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 25 UG, 1X/DAY | Y | 21301 | 25 | UG | TABLET | QD | |||||
| 93010622 | 9301062 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | MG | 0 | QD | |||||||||
| 93010622 | 9301062 | 5 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | BID | |||||||
| 93010622 | 9301062 | 6 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0.45 MG, 1X/DAY | 0 | .45 | MG | QD | |||||||
| 93010622 | 9301062 | 7 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 100 MG, 2X/DAY | 0 | 100 | MG | BID | |||||||
| 93010622 | 9301062 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, QHS | 0 | 40 | MG | ||||||||
| 93010622 | 9301062 | 9 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 37.5 MG, 3X/DAY | 0 | 37.5 | MG | TID | |||||||
| 93010622 | 9301062 | 10 | C | LEVOBUNOLOL 85% | 2 | 1 T GTT, QD | 0 | QD | |||||||||||
| 93010622 | 9301062 | 11 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Oral | 1 TAB, QD | 0 | QD | |||||||||
| 93010622 | 9301062 | 12 | C | OSTEO BI-FLEX | CHONDROITIN SULFATE AGLUCOSAMINE | 1 | Oral | 1 TAB, QD | 0 | QD | |||||||||
| 93010622 | 9301062 | 13 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 2000UNITS, QD | 0 | QD | |||||||||
| 93010622 | 9301062 | 14 | C | CALCIUM | CALCIUM | 1 | Oral | 600 UNITS, QD | 0 | QD | |||||||||
| 93010622 | 9301062 | 15 | C | FISH OIL | FISH OIL | 1 | Oral | 2 CAPS, QD | 0 | QD | |||||||||
| 93010622 | 9301062 | 16 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 2 TABS, PRN | 0 | ||||||||||
| 93010622 | 9301062 | 17 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
| 93010622 | 9301062 | 18 | C | ALEVE | NAPROXEN SODIUM | 1 | Oral | 2 TABS, PRN | 0 | ||||||||||
| 93010622 | 9301062 | 19 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 2 TAB, PRN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93010622 | 9301062 | 1 | Osteoarthritis |
| 93010622 | 9301062 | 2 | Rheumatoid arthritis |
| 93010622 | 9301062 | 3 | Hypothyroidism |
| 93010622 | 9301062 | 4 | Prophylaxis |
| 93010622 | 9301062 | 5 | Hypertension |
| 93010622 | 9301062 | 6 | Benign prostatic hyperplasia |
| 93010622 | 9301062 | 7 | Hypertension |
| 93010622 | 9301062 | 8 | Dyslipidaemia |
| 93010622 | 9301062 | 9 | Hypertension |
| 93010622 | 9301062 | 10 | Glaucoma |
| 93010622 | 9301062 | 11 | Supplementation therapy |
| 93010622 | 9301062 | 12 | Supplementation therapy |
| 93010622 | 9301062 | 13 | Supplementation therapy |
| 93010622 | 9301062 | 14 | Supplementation therapy |
| 93010622 | 9301062 | 15 | Supplementation therapy |
| 93010622 | 9301062 | 16 | Arthritis |
| 93010622 | 9301062 | 17 | Gastrooesophageal reflux disease |
| 93010622 | 9301062 | 18 | Arthralgia |
| 93010622 | 9301062 | 19 | Arthralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93010622 | 9301062 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93010622 | 9301062 | Atrial fibrillation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93010622 | 9301062 | 1 | 20110726 | 20110810 | 0 | |
| 93010622 | 9301062 | 3 | 20120202 | 0 | ||
| 93010622 | 9301062 | 4 | 20110726 | 20110810 | 0 | |
| 93010622 | 9301062 | 5 | 2008 | 0 | ||
| 93010622 | 9301062 | 6 | 2008 | 0 | ||
| 93010622 | 9301062 | 7 | 2008 | 0 | ||
| 93010622 | 9301062 | 8 | 20110916 | 0 | ||
| 93010622 | 9301062 | 9 | 1991 | 0 | ||
| 93010622 | 9301062 | 10 | 1991 | 0 | ||
| 93010622 | 9301062 | 11 | 2006 | 0 | ||
| 93010622 | 9301062 | 12 | 2006 | 0 | ||
| 93010622 | 9301062 | 13 | 20111016 | 0 | ||
| 93010622 | 9301062 | 14 | 2006 | 0 | ||
| 93010622 | 9301062 | 15 | 2011 | 0 | ||
| 93010622 | 9301062 | 16 | 20110923 | 0 | ||
| 93010622 | 9301062 | 17 | 20110811 | 0 | ||
| 93010622 | 9301062 | 18 | 20111101 | 0 | ||
| 93010622 | 9301062 | 19 | 20111101 | 0 |